Clinical trials during the COVID-19 pandemic: A global guide

Clinical trial continuity represents a key challenge for pharmaceutical companies during the COVID-19 pandemic. Regulators have introduced temporary measures to facilitate trial sponsors, who are now confronting shifting landscapes. Our global Life Sciences team navigates through the clinical trials regulatory environment across more than 40 countries worldwide.